UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Transcat
TRNS
$871M
| $298K | ﹤0.01% |
+4,200
| New | +$320K |
|
2277
UWM Holdings
UWMC
$434M
| $297K | ﹤0.01% |
89,830
-7,112
| -7% | -$26.7K |
|
2278
Old Second Bancorp
OSBC
$1.29B
| $296K | ﹤0.01% |
18,482
| – | – |
|
2279
TaskUs
TASK
$669M
| $296K | ﹤0.01% |
17,533
+2,811
| +19% | +$52.8K |
|
2280
BioXcel Therapeutics
BTAI
$27.8M
| $294K | ﹤0.01% |
857
| – | – |
|
|
ATSG
2281
DELISTED
Air Transport Services Group
ATSG
| $294K | ﹤0.01% |
11,319
-408
| -3% | -$11.2K |
|
|
DX
2282
Dynex Capital
DX
$3.21B
| $292K | ﹤0.01% |
22,941
+4,130
| +22% | +$51.1K |
|
2283
Inogen
INGN
$164M
| $292K | ﹤0.01% |
14,798
| – | – |
|
|
AMPS
2284
DELISTED
Altus Power
AMPS
| $292K | ﹤0.01% |
44,718
| – | – |
|
|
MOFG
2285
DELISTED
MidWestOne Financial Group
MOFG
| $291K | ﹤0.01% |
+9,164
| New | +$295K |
|
2286
Coastal Financial
CCB
$693M
| $290K | ﹤0.01% |
+6,100
| New | +$283K |
|
2287
Purple Innovation
PRPL
$41.7M
| $289K | ﹤0.01% |
2,415
| – | – |
|
2288
Frontline
FRO
$8.85B
| $289K | ﹤0.01% |
23,786
-36,261
| -60% | -$466K |
|
2289
Peapack-Gladstone Financial
PGC
$812M
| $285K | ﹤0.01% |
7,664
| – | – |
|
2290
Tejon Ranch
TRC
$451M
| $284K | ﹤0.01% |
15,069
| – | – |
|
2291
Accel Entertainment
ACEL
$987M
| $284K | ﹤0.01% |
36,827
-15,994
| -30% | -$137K |
|
2292
BrightView Holdings
BV
$1.07B
| $283K | ﹤0.01% |
41,129
-4,500
| -10% | -$34.7K |
|
|
AGTI
2293
DELISTED
Agiliti Inc
AGTI
| $282K | ﹤0.01% |
17,313
+2,711
| +19% | +$44.8K |
|
2294
Karyopharm Therapeutics
KPTI
$48M
| $282K | ﹤0.01% |
5,525
+724
| +15% | +$50.2K |
|
2295
Nuvation Bio
NUVB
$2.32B
| $281K | ﹤0.01% |
146,590
+4,216
| +3% | +$8.53K |
|
2296
Cardlytics
CDLX
$21.5M
| $280K | ﹤0.01% |
4,838
-31
| -0.6% | -$1.92K |
|
2297
iShares Russell 1000 Growth ETF
IWF
$128B
| $279K | ﹤0.01% |
+5,200
| New | +$286K |
|
|
BFS
2298
Saul Centers
BFS
$841M
| $278K | ﹤0.01% |
6,844
| – | – |
|
2299
REX American Resources
REX
$1.41B
| $278K | ﹤0.01% |
17,454
| – | – |
|
2300
Heron Therapeutics
HRTX
$92.9M
| $277K | ﹤0.01% |
110,752
| – | – |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.